Evidence map›Paper›PMID 33781934›Full record

Observational studyAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2021

Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease.

Patrick J Staso, Pingsheng Wu, Tanya M Laidlaw, Katherine N Cahill

Open access · greenAbstract readLetterObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Patrick J StasoDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Pingsheng WuDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Tanya M LaidlawDivision of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Katherine N CahillDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: Katherine.cahill@vumc.org.
Vanderbilt University Medical Center · USHarvard University · US

Funding

Prostaglandin D2: A Key Mediator of Aspirin-Exacerbated Respiratory DiseaseR01HL128241 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LAIDLAW, TANYA MARIA · 2015 to 2019
$2.2M
THE ROLE OF PROSTAGLANDIN D2 IN THE RESPIRATORY SYMPTOMS OF ASPIRIN EXACERBATED RESPIRATORY DISEASEK23AI118804 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAHILL, KATHERINE N · 2015 to 2019
$951k
NHLBI NIH HHS R01 HL128241NIAID NIH HHS K23 AI118804
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, IntranasalAdultAspirinCyclooxygenase InhibitorsDose-Response Relationship, DrugDrug HypersensitivityEnzyme-Linked Immunosorbent AssayFemaleHumansLeukotrienesMaleNasal Lavage FluidNasal Provocation TestsProspective StudiesProstaglandinsRespiratory Tract DiseasesAspirinCyclooxygenase InhibitorsLeukotrienesProstaglandins

Identifiers

PMID33781934
PMCPMC8222107
OpenAlexW3143805271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.